業績 | 徳島大学大学院医歯薬研究部　血液・内分泌代謝内科学分野

English Paper

英文論文

Year	Month
2025		Fibrosis-4 and 3 indices are independently associated with annual hemoglobin decline in individuals with metabolic disorders: A hospital-based retrospective cohort study.
		Hori T, Aihara K, Kawano Y, Watanabe T, Kaneko Y, Kawata S, Shimizu K, Hosoki M, Mori K, Otoda T, Yuasa T, Matsuoka K, Nakamura S.
		Correction: JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM).
		Iida S, Ito S, Sunami K, Takamatsu H, Tsukada N, Hosen N, Miki H.
		JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 2. Related disorders of multiple myeloma.
		Iida S, Ito S, Sunami K, Takamatsu H, Tsukada N, Hosen N, Miki H, Fuchida SI, Sakaida E.
		Novel noninvasive parameters for diagnosis of liver involvement in patients with systemic AL amyloidosis.
		Sumitani R, Miki H, Nakamura S, Nakamura M, Hori T, Maeda Y, Oura M, Sogabe K, Yagi H, Takahashi M, Harada T, Fujii S, Okada N, Nishio S, Tomonari T, Abe M, Matsuoka KI.
		Myeloma cell growth suppression by osteoblast-derived extracellular vesicles: the creation of a non-permissive niche for myeloma cells by bone-forming osteoblasts.
		Kim S, Teramachi J, Hiasa M, Amachi R, Bat-Erdene A, Oda A, Tenshin H, Tanaka M, Nakagawa M, Seki A, Sawa Y, Matsuoka KI, Tanaka E, Harada T, Tominaga T, Abe M.
		Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction.
		Inoue Y, Tenshin H, Teramachi J, Sumitani R, Oda A, Maeda Y, Oura M, Sogabe K, Maruhashi T, Takahashi M, Fujii S, Nakamura S, Miki H, Hara T, Endo I, Kagawa K, Ozaki S, Hiasa M, Harada T, Abe M.
		False-Positive Galactomannan Test Results in Multiple Myeloma.
		Nakamura S, Maeda Y, Sumitani R, Oura M, Sogabe K, Yagi H, Fujii S, Harada T, Matsuoka KI, Miki H.
		Allogeneic haematopoietic stem cell transplantation and patient falls: impact of lower extremity muscle strength.
		Kondo S, Inoue T, Saito T, Kawamura Y, Katayama A, Nakamura M, Sumitani R, Takahashi M, Oura M, Sogabe K, Harada T, Fujii S, Nakamura S, Miki H, Kagawa K, Sato N, Ono R, Abe M, Katoh S.
		Effective Intractable Chylous Ascites Treatment by Lymphangiography with Lipiodol in a Patient with Follicular Lymphoma.
		Sumitani R, Higashi K, Oura M, Maeda Y, Yagi H, Sogabe K, Takahashi M, Harada T, Fujii S, Miki H, Abe M, Nakamura S.
		Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice.
		Hara T, Yamagami H, Uemoto R, Sekine A, Kaneko Y, Miyataka K, Hori T, Ichimura-Shimizu M, Funamoto M, Harada T, Yuasa T, Nakamura S, Endo I, Matsuoka KI, Kawano Y, Tsuneyama K, Ikeda Y, Aihara KI.
		Mean Corpuscular Volume Is Correlated with Liver Fibrosis Defined by Noninvasive Blood Biochemical Indices in Individuals with Metabolic Disorders Aged 60 Years or Older.
		Kaneko Y, Kawano Y, Kawata S, Mori K, Hosoki M, Hori T, Miyataka K, Tsuji S, Hara T, Yamagami H, Otoda T, Yuasa T, Kuroda A, Harada T, Miki H, Nakamura S, Endo I, Matsuhisa M, Matsuoka KI, Aihara KI.
		Red blood cell distribution width is associated with renal tubular injury in individuals with type 2 diabetes.
		Miyataka K, Kaneko Y, Hori T, Yamaguchi Y, Tsuji S, Hara T, Yamagami H, Yoshida S, Otoda T, Yuasa T, Kuroda A, Harada T. Miki H, Nakamura S, Endo I, Matsuhisa M, Matsuoka KI, Aihara KI.
		Preparedness for the future in patients with relapsed or refractory hematopoietic malignancies in the treatment process: a qualitative study.
		Akashi K, Imai Y, Nakamura S, Maeda Y, Sumitani R, Oura M, Sogabe K, Takahashi M, Fujii S, Harada T, Miki H.
		Hematology in community medical care.
		Nakamura S, Maeda Y, Hori T, Oura M.
		Congenital hypofibrinogenemia with a novel mutation BβCys76Phe.
		Sugasaki M, Nakamura S, Arai S, Teramoto K, Urushihara M, Inoue Y, Nakao T, Nishioka Y, Sata M.
		Detection of Hematological Malignancies Using N-NOSE (Nematode-NOSE).
		Nakamura S, Hatakeyama H, Yoshida S, Ungkulpasvich U, Hirotsu T, di Luccio E, Abe M.
		Isolated adrenocorticotropic hormone deficiency presenting with arthritis: A case report.
		Yamashita Y, Sato S, Nii K, Mori K, Haji K, Naito N, Ogino H, Kawawno H, Hanibuchi M, Endo I, Nishioka Y.
		Plantar pressure and shear stress during gait in people with diabetic neuropathy.
		Mima S, Abe Y, Yamasaki H, Bando M, Nagasaka S, Yamashita Y, Mineda K, Yoshida S, Endo I, Matsuhisa M, Takaiwa M, Hashimoto I.
		Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes.
		Hara T, Watanabe T, Yamagami H, Miyataka K, Yasui S, Asai T, Kaneko Y, Mitsui Y, Masuda S, Kurahashi K, Otoda T, Yuasa T, Kuroda A, Endo I, Honda S, Kondo A, Matsuhisa M and Aihara KI.
		Quality of skeletal muscles during allogeneic stem-cell transplantation: a pilot study. BMJ Support Palliat Care.
		Maeda Y, Takao S, Morita S, Kondo S, Yamashita M, Sumitani R, Oura M, Sogabe K, Takahashi M, Fujii S, Harada T, Miki H, Abe M, Nakamura S.
		Longitudinal Changes of BMI and Renal Function Biomarkers During the Final 3 Years of Life Among Hospitalized Patients with Schizophrenia in Japan: A Preliminary Study.
		Mifune Y, Ito H, Soriano K, Bollos AL, Akiyama T, Osaka K, Umehara H, Endo I, Kwan YCR, Tang CYA, Mifune K, Tanioka T.
2024		Humoral immune response against SARS-CoV-2 and polyethylene glycol elicited by anti-SARS-CoV-2 mRNA vaccine, and effect of pre-existing anti polyethylene glycol antibody in patients with hematological and autoimmune diseases. Heliyon.
		Hori T, Shimizu T, Ando H, Okada N, Yamagami H, Yasui S, Hosoki M, Tojima A, Otoda T, Yuasa T, Aihara KI, Takishita M, Yoshida S, Abe M, Ishida T, Nakamura S.
		The Respiratory Adjusted Shock Index at Admission Is a Valuable Predictor of In-Hospital Outcomes for Elderly Emergency Patients with Medical Diseases at a Japanese Community General Hospital.
		Hori T, Aihara K, Watanabe T, Inaba K, Inaba K, Kaneko Y, Kawata S, Kawahito K, Kita H, Shimizu K, Hosoki M, Mori K, Kageji T, Uraoka H, Nakamura S.
		Usefulness of Palliative Prognostic Index, Objective Prognostic Score, and Neutrophil-Lymphocyte Ratio/Albumin Ratio As Prognostic Indicators for Patients Without Cancer Receiving Home-Visit Palliative Care: A Pilot Study at a Community General Hospital.
		Hori T, Aihara KI, Ishida K, Inaba K, Inaba K, Kaneko Y, Kawahito K, Bekku S, Hosoki M, Mori K, Itami K, Katsuse M, Hanaoka Y, Kageji T, Uraoka H, Nakamura S.
		ctDNA improves prognostic prediction in relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone.
		Kogure Y, Handa H, Ito Y, Ri M, Horigome Y, Iino M, Harazaki Y, Kobayashi T, Abe M, Ishida T, Ito S, Iwasaki H, Kuroda J, Shibayama H, Sunami K, Takamatsu H, Tamura H, Hayashi T, Akagi K, Shinozaki T, Yoshida T, Mori I, Iida S, Maeda T, Kataoka K.
		Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal Prognosis.
		Masuda S, Hara T, Yamagami H, Mitsui Y, Kurahashi K, Yoshida S, Harada T, Otoda T, Yuasa T, Nakamura S, Kuroda A, Endo I, Matsumoto T, Matsuhisa M, Abe M, Aihara KI.
		Clinical impact of anti-polyethylene glycol (PEG) antibody in haematological patients administered PEGylated-granulocyte colony-stimulating factor.
		Okada N, Taro S, Ando H, Nakamura S, Goda M, Abe M, Kitahara T, Ishida T, Ishizawa K.
		Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors.
		Nakaue E, Teramachi J, Tenshin H, Hiasa M, Harada T, Oda A, Inoue Y, Shimizu S, Higa Y, Sogabe K, Oura M, Hara T, Sumitani R, Maruhashi T, Yamagami H, Endo I, Tanaka E, Abe M.
		Autosomal Recessive Spinocerebellar Ataxia Type 9 With a Response to Phosphate Repletion: A Case Report
		Haji S, Miyamoto R, Morino H, Osaki Y, Tsuji S, Nishino I, Abe, M and Izumi Y.
		Sarcopenia phenotype and impaired muscle function in male mice with fast-twitch muscle-specific knockout of the androgen receptor.
		Hosoi T, Yakabe M, Sasakawa H, Sasako T, Ueki K, Kato S, Tokuoka SM, Oda Y, Abe M, Matsumoto T, Akishita M, Ogawa S.
		Single-cell RNA sequencing identifies Fgf23-expressing osteocytes in response to 1,25-dihydroxyvitamin D3 treatment.
		Hanai A, Kawabata A, Nakajima K, Masuda K, Urakawa I, Abe M, Yamazaki Y, Fukumoto S.
		The xanthine oxidase inhibitor febuxostat suppresses adipogenesis and activates Nrf2.
		Higa Y, Hiasa M, Tenshin H, Nakaue E, Tanaka M, Kim S, Nakagawa M, Shimizu S, Tanimoto K, Teramachi J, Harada T, Oda A, Oura M, Sogabe K, Hara T, Sumitani R, Maruhashi T, Yamagami H, Endo I, Matsumoto T, Tanaka E, Abe M.
		Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase.
		Harada T, Ohguchi H, Oda A, Nakao M, Teramachi J, Hiasa M, Sumitani R, Oura M, Sogabe K, Maruhashi T, Takahashi M, Fujii S, Nakamura S, Miki H, Kagawa K, Ozaki S, Sano S, Hideshima T, Abe M.
		Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents.
		Teramachi J, Miki H, Nakamura S, Hiasa M, Harada T, Abe M.
		CASE REPORT : Acute myeloid leukemia developed through myeloproliferative features during immunosuppressive therapy for juvenile idiopathic arthritis.
		Oura M, Sumitani R, Maeda Y, Yagi H, Takahashi M, Harada T, Fujii S, Miki H, Hori T, Murai J, Kagawa K, Abe M and Nakamura S. The Journal of Medical Investigation Vol. 71 2024.
		Quality of skeletal muscles during allogeneic stem-cell transplantation: a pilot study.
		Maeda Y, Takao S, Morita S, Kondo S, Yamashita M, Sumitani R, Oura M, Sogabe K, Takahashi M, Fujii S, Harada T, Miki H, Abe M, Nakamura S. BMJ Support Palliat Care. 2024 Oct 1:spcare-2024-005070. PMID: 39353719 DOI: 10.1136/spcare-2024-005070
		Effective Intractable Chylous Ascites Treatment by Lymphangiography with Lipiodol in a Patient with Follicular Lymphoma.
		Sumitani R, Higashi K, Oura M, Maeda Y, Yagi H, Sogabe K, Takahashi M, Harada T, Fujii S, Miki H, Abe M and Nakamura S. Intern Med. 2024 Sep 27. PMID: 39343573 DOI: 10.2169/internalmedicine.4175-24
		Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes.
		Hara T, Watanabe T, Yamagami H, Miyataka K, Yasui S, Asai T, Kaneko Y, Mitsui Y, Masuda S, Kurahashi K, Otoda T, Yuasa T, Kuroda A, Endo I, Honda S, Kondo A, Matsuhisa M and Aihara KI. Biomedicines 2024, 12, 1789.
		Discrimination between Toxoplasmic Encephalitis and Central Nervous System Lymphoma: An Updated Review.
		Nakamura S, Miki H. J Hematol Thrombo Dis, Vol.12 Iss.4 No:1000602
		Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study.
		Otoda T, Sekine A, Uemoto R, Tsuji S, Hara T, Tamaki M, Yuasa T, Tamaki T, Matsuhisa M, Aihara KI.　Diabetes Ther., 2024 Jan;15(1):127-143. doi: 10.1007/s13300-023-01488-0. Epub 2023 Oct 26.
		Silicone stent placement for tracheal stenosis induced by a giant goiter due to Graves' disease: a case report.
		Misaki M, Kawakita N, Hara T, Yamagami H, Takeuchi T, Miyamoto N, Sakamoto S, Inoue S, Goto M, Toba H, Takizawa H. Gland Surg., 2024 Apr 29;13(4):578-583. doi: 10.21037/gs-23-499.
		Familial cases with adult-onset FGF23-related hypophosphatemic osteomalacia -A PHEX 3’-UTR change as a possible cause-
		Sawatsubashi S, Takashi Y, Endo I, Kondo T, Abe M, Matsumoto T, Fukumoto S. Bone. 2024;182:117057. Epub 2024 feb 25
		Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1.
		Mai Kanai , Byambasuren Ganbaatar,Itsuro Endo, Yukiyo Ohnishi , Jumpei Teramachi Hirofumi Tenshin, Yoshiki Higa, Masahiro Hiasa, Yukari Mitsui, Tomoyo Hara, Shiho Masuda, Hiroki Yamagami, Yuki Yamaguchi, Ken-ichi Aihara, Mayu Sebe , Rie Tsutsumi, Hiroshi Sakaue, Toshio Matsumoto and Masahiro Abe. Int. J. Mol. Sci. 2024, 25, 5715.
		Toxoplasmic encephalitis with high 201Tl uptake and retention mimicking malignant lymphoma in a patient with human immunodeficiency virus infection.
		Nakamura S, Hara K, Kobayashi T, Sumitani R, Oura M, Maeda Y, Sogabe K , Yagi H, Takahashi M, Fujii S , Harada T , Bando Y , Abe M, Miki H. Parasitol Int. 2024 Apr 12:101:102895.
		Clinical Significance of Phase Angle and Extracellular Water-to-Total Body Water Ratio Measured by Bioelectrical Impedance Analysis.
		Hori T, Nakamura S, Aihara KI. Journal of Leukemia, Mini Review - (2024)Volume 12, Issue 2
		Skeletal muscle mass during chemotherapy for haematological malignancies: a retrospective study. BMJ Support Palliat Care.
		Takahashi M, Kondo S, Kagawa K, Nakamura M, Maeda Y, Sumitani R, Yagi H, Oura M, Sogabe K, Harada T, Fujii F, Miki H, Endo I, Abe M, Nakamura S. BMJ Support Palliat Care. 2024 Apr 3:spcare-2024-004870.
		Usefulness of Palliative Prognostic Index, Objective Prognostic Score, and Neutrophil–Lymphocyte Ratio/Albumin Ratio As Prognostic Indicators for Patients Without Cancer Receiving Home-Visit Palliative Care: A Pilot Study at a Community General Hospital.
		Hori T, Aihara KI, Ishida K, Inaba K, Inaba K, Kaneko Y, Kawahito K, Bekku S, Hosoki M, Mori K, Itami K, Katsuse M, Hanaoka Y, Kageji T, Uraoka H, Nakamura S. Palliative Medicine Reports, Volume 5.1, 2024 DOI: 10.1089/pmr.
		Raman Microspectroscopy for Label-Free Diagnosis of AL Amyloidosis in Various Organs.
		Yanagiya S, Honda T, Takanari H, Sogabe K, Nakamura S, BandoY, Tsuneyama K, Abe M, Miki H. Journal of Raman Spectroscopy. 2024, 55(7): 753-760
		Causes of In-Hospital Death and Pharmaceutical Associations with Age of Death during a 10-Year Period (2011–2020) in Individuals with and without Diabetes at a Japanese Community General Hospital.
		Hosoki M, Hori T, Kaneko Y, Mori K, Yasui S, Tsuji S, Yamagami H, Kawata S, Hara T, Masuda S, Mitsui Y, Kurahashi K, Harada T, Nakamura S, Otoda T, Yuasa T, Kuroda A, Endo I, Matsuhisa M and Aihara KI. J. Clin. Med. 2024, 13(5), 1283.
		A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.
		Horigome Y, Iino M, Harazaki Y, Kobayashi T, Handa H, Hiramatsu Y, Kuroi T, Tanimoto K, Matsue K, Abe M, Ishida T, Ito S, Iwasaki H, Kuroda J, Shibayama H, Sunami K, Takamatsu H, Tamura H, Hayashi T, Akagi K, Maeda T, Yoshida T, Mori I, Shinozaki T, Iida S. Ann Hematol. 2024 Feb;103(2):475-488.
		In vivo treatment with calcilytic of CaSR knock-in mice ameliorates renal phenotype reversing downregulation of the vasopressin-AQP2 pathway.
		Marianna Ranieri, Ines Angelini, Mariagrazia D'Agostino, Annarita Di Mise, Mariangela Centrone, Maria Venneri, Angela Ferrulli, Maria Mastrodonato, Grazia Tamma, Itsuro Endo, Seiji Fukumoto, Toshio Matsumoto, and Giovanna Valenti. J Physiol. 2024 Jul;602(13):3207-3224.
		Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib.
		Maruhashi T, Miki H, Sogabe K, Oda A, Sumitani R, Oura M, Takahashi M, Harada T, Fujii S, Nakamura S, Kurahashi K, Endo I, Abe M. Int J Hematol. 2024 Mar;119(3):291-302. PMID: 38252236
		Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
		Sogabe K, Nakamura S, Higa Y, Miki H, Oda A, Maruhashi T, Sumitani R, Oura M, Takahashi M, Nakamura M, Maeda Y, Hara T, Yamagami H, Fujii S, Kagawa K, Ozaki S, Kurahashi K, Endo I, Aihara KI, Nakaue E, Hiasa M, Teramachi J, Harada T, Abe M. Int J Hematol. 2024 Mar;119(3):303-315.PMID: 38245883
		Bone-fat linkage via interleukin-11 in response to mechanical loading.
		Hiasa M, Endo I, Matsumoto T. Life Sci Alliance. 2023 Sep 6;6(11)PMID: 38324177 DOI: 10.1007/s00774-023-01493-0
2023		Cross-sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes.
		Yamagami H, Hara T, Yasui S, Hosoki M, Hori T, Kaneko Y, Mitsui Y, Kurahashi K, Harada T, Yoshida S, Nakamura S, Otoda T, Yuasa T, Kuroda A, Endo I, Matsuhisa M, Abe M, Aihara KI. Biomedicines. 11(11):3020, 2023. PMID: 38002020
		Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphoma.
		Oura M, Harada T, Oda A, Teramachi J, Nakayama A, Sumitani R, Inoue Y, Maeda Y, Sogabe K, Maruhashi T, Takahashi M, Fujii S, Nakamura S, Miki H, Nakamura M, Hara T, Yamagami H, Kurahashi K, Endo I, Hasegawa H, Fujiwara H, Abe M. EJHaem. 4(3):667-678, 2023. PMID: 37601887
		Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus.
		Hara T, Uemoto R, Sekine A, Mitsui M, Masuda S, Yamagami H, Kurahashi K, Yoshida S, Otoda T, Yuasa T, Kuroda A, Ikeda Y, Endo I, Honda S, Yoshimoto K, Kondo A, Tamaki T, Matsumoto T, Matsuhisa M, Abe M, Aihara KI. J Atheroscler Thromb. 2023 Aug 1;30(8):871-883. PMID: 36244745
		Dehydroepiandrosterone Sulfate, an Adrenal Androgen, Is Inversely Associated with Prevalence of Dynapenia in Male Individuals with Type 2 Diabetes.
		Yasui S, Kaneko Y, Yamagami H, Hosoki M, Hori T, Tani A, Hara T, Kurahashi K, Harada T, Nakamura S, Otoda T, Yuasa T, Mori H, Kuroda A, Endo I, Matsuhisa M, Soeki T, Aihara KI. Metabolites. 2023 Nov 3;13(11):1129. PMID: 37999225
		VDR is an essential regulator of hair follicle regression through the progression of cell death.
		Joko Y, Yamamoto Y, Kato S, Takemoto T, Abe M, Matsumoto T, Fukumoto S, Sawatsubashi S. Life Sci Alliance. 6(11):e202302014, 2023. PMID: 37673445
		Atypical femoral fracture in a multiple myeloma patient undergoing treatment with denosumab: A case report and literature review.
		Omichi Y, Toki S, Nishisho T, Harada T, Sato N, Sairyo K. Int J Surg Case Rep, Volume 108, July 2023, 108456. PMID: 37421768
		ctDNA improves prognostic prediction in relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone.
		Kogure Y, Handa H, Ito Y, Ri M, Horigome Y, Iino M, Harazaki Y, Kobayashi T, Abe M, Ishida T, Ito S, Iwasaki H, Kuroda J, Shibayama H, Sunami K, Takamatsu H, Tamura H, Hayashi T, Akagi K, Shinozaki T, Yoshida T, Mori I, Iida S, Maeda T, Kataoka K. Blood. 2024 Jun 6;143(23):2401-2413.
		Phase angle and extracellular water-to-total body water ratio estimated by bioelectrical impedance analysis are associated with levels of hemoglobin and hematocrit in patients with diabetes.
		Hori T, Nakamura S, Yamagami H, Yasui S, Hosoki M, Hara T, Mitsui Y, Masuda S, Kurahashi K, Yoshida S, Harada T, Kuroda A, Otoda T, Yuasa T, Endo I, Matsuhisa M, Abe M, Aihara KI. Heliyon. 2023 Mar 21;9(4):e14724. PMID: 37057050
		Clinical impact of anti-polyethylene glycol (PEG) antibody in haematological patients administered PEGylated-granulocyte colony-stimulating factor.
		Okada N, Taro S, Ando H, Nakamura S, Goda M, Abe M, Kitahara T, Ishida T, Ishizawa K. Clin Pharmacol Drug Dev. 2023 Aug;12(8):826-831. PMID: 36708147
		Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal Prognosis.
		Masuda S, Hara T, Yamagami H, Mitsui Y, Kurahashi K, Yoshida S, Harada T, Otoda T, Yuasa T, Nakamura S, Kuroda A, Endo I, Matsumoto T, Matsuhisa M, Abe M, Aihara KI. J Atheroscler Thromb. 2023 Nov 1;30(11):1727-1741.PMID: 37081616
		Autosomal recessive spinocerebellar ataxia type 9 with a response to phosphate repletion: A case report.
		Haji S, Miyamoto R, Morino H, Osaki Y, Tsuji S, Nishino I, Abe M, and Izumi Y. Neurol Genet 2023;9:e200070.
		Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors.
		Nakaue E, Teramachi J, Tenshin H, Hiasa M, Harada T, Oda A, Inoue Y, Shimizu S, Higa Y, Sogabe K, Oura M, Hara T, Sumitani R, Maruhashi T, Yamagami H, Endo I, Tanaka E, Abe M. Int J Hematol. 2023 Jul;118(1):88-98.
		Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase.
		Harada T, Ohguchi H, Oda A, Nakao M, Teramachi J, Hiasa M, Sumitani R, Oura M, Sogabe K, Maruhashi T, Takahashi M, Fujii S, Nakamura S, Miki H, Kagawa K, Ozaki S, Sano S, Hideshima T, Abe M. Blood Adv. 2023 Mar 28;7(6):1019-1032. doi: 10.1182/bloodadvances.2022007155.PMID: 36129197
		The xanthine oxidase inhibitor febuxostat suppresses adipogenesis and activates Nrf2.
		Higa Y, Hiasa M, Tenshin H, Nakaue E, Tanaka M, Kim S, Nakagawa M, Shimizu S, Tanimoto K, Teramachi J, Harada T, Oda A, Oura M, Sogabe K, Hara T, Sumitani R, Maruhashi T, Yamagami H, Endo I, Matsumoto T, Tanaka E, Abe M. Antioxidants. 2023;12(1):133　doi: 10.3390/antiox12010133.　PMID: 36670994 PMCID: PMC9854541
		Sarcopenia phenotype and impaired muscle function in male mice with fast-twitch muscle-specific knockout of the androgen receptor.
		Hosoi T, Yakabe M, Sasakawa H, Sasako T, Ueki K, Kato S, Tokuoka SM, Oda Y, Abe M, Matsumoto T, Akishita M, Ogawa S. Proc Natl Acad Sci U S A. 2023 Jan 24;120(4):e2218032120. doi: 10.1073/pnas.2218032120. Epub 2023 Jan 20.PMID: 36669097
		Single-cell RNA sequencing identifies Fgf23-expressing osteocytes in response to 1,25-dihydroxyvitamin D3 treatment.
		Hanai A, Kawabata A, Nakajima K, Masuda K, Urakawa I, Abe M, Yamazaki Y, Fukumoto S. Front Physiol. 2023 Jan 27;14:1102751. doi: 10.3389/fphys.2023.1102751. eCollection 2023.PMID: 36776964
		Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents.
		Teramachi J, Miki H, Nakamura S, Hiasa M, Harada T, Abe M.J Bone Miner Metab. 2023 Mar 1:1-16. doi: 10.1007/s00774-023-01403-4. PMID: 36856824
2022		First reported case of Lachnoanaerobaculum gingivalis bacteremia in an acute myeloid leukemia patient with oral mucositis during high dose chemotherapy.
		Okada N, Murakami A, Sato M, Nakamura S, Fujii S, Sogabe K, Takahashi M, Okada A, Abe A, Fujii H, Abe M, Azuma M, Ishizawa K. Anaerobe. 2022 Aug;76:102610. doi: 10.1016/j.anaerobe.2022.102610. Epub 2022 Jul 8. PMID: 35811059.
		Autoimmune Acquired Factor XIII/13 Deficiency after SARS-CoV-2 mRNA Vaccination.
		Nakamura S, Sugasaki M, Souri M, Akazawa H, Sogawa M, Hori T, Yamagami H, Takishita M, Aihara KI, Abe M, Yasumoto A, Morishita E, Ichinose A. Thromb Haemost. 2022 Oct;122(10):1837-1842. doi: 10.1055/a-1863-7265. Epub 2022 May 30.PMID: 35636450
		Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan.
		Miyamoto-Nagai Y, Mimura N, Tsukada N, Aotsuka N, Ri M, Katsuoka Y, Wakayama T, Suzuki R, Harazaki Y, Matsumoto M, Kumagai K, Miyake T, Ozaki S, Shono K, Tanaka H, Shimura A, Kuroda Y, Sunami K, Suzuki K, Yamashita T, Shimizu K, Murakami H, Abe M, Nakaseko C, Sakaida E. eJHaem. 2022 Jul 21;3(3):838-848. doi: 10.1002/jha2.534. eCollection 2022 Aug.PMID: 36051061
		Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus.
		Hara T, Uemoto R, Sekine A, Mitsui Y, Masuda S, Yamagami H, Kurahashi K, Yoshida S, Otoda T, Yuasa T, Kuroda A, Ikeda Y, Endo I, Honda S, Yoshimoto K, Kondo A, Tamaki T, Matsumoto T, Matsuhisa M, Abe M, Aihara KI. J Atheroscler Thromb. 2022 Oct 14. doi: 10.5551/jat.63752. Online ahead of print.PMID: 36244745
		Osteoblast/osteocyte-derived interleukin-11 regulates osteogenesis and systemic adipogenesis.
		Dong B, Hiasa M, Higa Y, Ohnishi Y, Endo I, Kondo T, Takashi Y, Tsoumpra M, Kainuma R, Sawatsubashi S, Kiyonari H, Shioi G, Sakaue H, Nakashima T, Kato S, Abe M, Fukumoto S, Matsumoto T. Nat Commun. 2022 Nov 23;13(1):7194. PMID: 36424386
		Novel method utilizing bisulfite conversion with dual amplification-refractory mutation system polymerase chain reaction to detect circulating pancreatic β-cell cfDNA.
		Okada A, Yamada-Yamashita M, Tominaga Y, Jo K, Mori H, Suzuki R, Ishizu M, Tamaki M, Akehi Y, Takashi Y, Koga D, Shimokita E, Tanihara F, Kurahashi K, Yoshida S, Mitsui Y, Masuda S, Endo I, Aihara K, Kagami S, Abe M, Ferreri K, Fujitani Y, Matsuhisa M and Kuroda A. Journal of Diabetes Investigation, 2022, Jul;13(7):1140-1148. PMID: 35396829
		Mechanical unloading aggravates bone destruction and tumor expansion in myeloma.
		Tanimoto K, Hiasa M, Tenshin H, Teramachi J, Oda A, Harada T, Higa Y, Sogabe K, Oura M, Sumitani R, Hara T, Endo I, Matsumoto T, Tanaka E, Abe M. Haematologica. 2022 Mar 1;107(3):744-749. PMID: 34788982
		A Genome-Wide Association Study Predicts the Onset of Dysgeusia Due to Anti-cancer Drug Treatment.
		Takei M, Okada N, Nakamura S, Kagawa K, Fujii S, Miki H, Ishizawa K, Abe M, Sato S. Biol Pharm Bull. 2022 Jan 1;45(1):114-117.
		TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expression.
		Tenshin H, Teramachi J, Ashtar M, Hiasa M, Inoue Y, Oda A, Tanimoto K, Shimizu S, Higa Y, Harada T, Oura M, Sogabe K, Hara T, Sumitani R, Maruhashi T, Sebe M, Tsutsumi R, Sakaue H, Endo I, Matsumoto T, Tanaka E, Abe M. Clin Transl Immunology. 2022 Jan 19;11(1):e1371. PMID: 35079379
		Aberrant upregulation of the endogenous PP2A inhibitor CIP2A is vital for myeloma cell growth and survival.
		Shimizu S, Teramachi J, Harada T, Hiasa M, Tenshin H, Oda A, Seki A, Inoue Y, Tanimoto K, Higa Y, Oura M, Sogabe K, Hara T, Sumitani R, Maruhashi T, Yamagami H, Sawa Y, Endo I, Tsuneyama K, Matsumoto T, Tanaka E and Abe M. International Journal of Myeloma. 2022;12(2):14-23.
		An attempt to create a treatment algorithm of central adrenal insufficiency using CRH test, DHEA-S and clinical evaluation.
		Mitsui Y, Iizuka Y, Tanaka T, Hara T, Masuda S, Ohnishi Y, Kanai M, Kurahashi K, Yoshida S, Kondo T, Kanezaki T, Shintani Y, Yamagami H, Yamaguchi Y, Fujinaka Y, Morimoto K, Shirakami A, Aihara KI, Fukumoto S, Abe M, Endo I. J Med Invest. 2022;69(3.4):287-293. PMID: 36244782
		The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone disease.
		Miki H, Nakamura S, Oura M, Nakamura M, Sumitani R, Sogabe K, Takahashi M, Maruhashi T, Harada T, Fujii S, Hamano H, Kondo M, Okada N, Endo I, Abe M. eJHaem. 2022 Feb 28;3(2):480-483. PMID: 35846024
		Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.
		Fuchida S, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto M, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H. Transplantation and Cellular Therapy. Volume 28, Issue 2, February 2022, Pages 76-82.
		Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index.
		Mitsui Y, Kuroda A, Ishizu M, Mori H, Kurahashi K, Kondo T, Yoshida S, Akehi Y, Aihara KI, Endo I, Abe M, Matsuhisa M. J Diabetes Investig. 2022 Feb;13(2):292-298.
2025		Novel noninvasive parameters for diagnosis of liver involvement in patients with systemic AL amyloidosis.
		Sumitani R, Miki H, Nakamura S, Nakamura M, Hori T, Maeda Y, Oura M, Sogabe K, Yagi H, Takahashi M, Harada T, Fujii S, Okada N, Nishio S, Tomonari T, Abe M, Matsuoka KI. Int J Hematol. 2025 Oct 27. doi: 10.1007/s12185-025-04082-1.

Japanese Paper

和文論文

Year	Month
		【原著・症例報告】
2025		4) 多発性骨髄腫における骨病変の分子病態とその管理三木浩和
		三木浩和. 臨床血液, 66巻9号 P. 1108-1116
2024		徳島大学病院における術前貯血式自己血採血集約化の取り組み −VVR発症例の検討と今後の課題−
		三木浩和, 瀧本朋美，高橋梨沙，佃恵里加, 小田直輝, 三木佐知子，尾形美子，三木こずえ，大浦雅博，曽我部公子，藤井志朗，山下一太，髙丸菜都美，西村正人，岩佐武. 日本輸血細胞治療学会誌2024 年 70 巻 6 号 p. 648-652
		周期性の発熱，胸背部痛をきたした家族性地中海熱の女性例 -AYA世代患者における多職種連携の重要性-
		新居寛子, 三木浩和，高橋真美子，岡本秀樹，前田悠作，住谷龍平，大浦雅博，曽我部公子，八木ひかる，丸橋朋子，原田武志，藤井志朗，中村信元，岩佐武，西小森隆太.　 四国医学雑誌80巻1,2号69-74, 2024
2022		徳島県におけるHIV感染症および後天性免疫不全症候群患者の臨床的特徴と今後の課題
		第264回徳島医学会学術集会第27回若手奨励賞受賞論文高原由実子, 三木浩和, 中村信元, 林成樹, 住谷龍平, 大浦雅博, 曽我部公子, 髙橋真美子, 丸橋朋子, 富永誠記, 岡本秀樹, 岡田直人, 矢野由美子, 高橋真理, 大坂朱美, 原田武志, 藤井志朗, 菅俊行, 青田桂子, 尾崎修治, 安倍正博. 四国医学雑誌78巻5.6号2022年
		少量methotrexate療法が有効であった進行期原発性皮膚未分化大細胞型リンパ腫
		住谷龍平, 原田武志, 中村昌史, 水口槙子, 大浦雅博, 曽我部公子, 丸橋朋子, 高橋真美子, 藤井志朗, 中村信元, 三木浩和, 賀川久美子, 矢田未央, 松立吉弘, 上原久典, 安倍正博. 臨床血液. 2022, 63(6), 536-543.
2021		繰り返す脆弱性骨折を契機に発見されたクッシング症候群の一例
		木村蘭子, 倉橋清衛, 細木美苗, 辻誠士郎, 三井由加里, 吉田守美子, 明比祐子, 遠藤逸朗, 福本誠二, 安倍正博. 四国医学雑誌, Vol.77, No.5-6, 269-274, 2021年
		TIA様症状を契機に診断されたインスリノーマの1例
		吉川紘平, 金子遥祐, 辻誠士郎, 河田沙紀, 川原綾香, 森建介, 遠藤ふうり, 原倫世, 倉橋清衛, 吉田守美子, 黒田暁生, 明比祐子, 遠藤逸朗, 船木真理, 福本誠二, 安倍正博, 松久宗英. 四国医学雑誌, Vol.77, No.5-6, 275-280, 2021年.
		循環血中遊離 DNA を用いた膵β細胞傷害の新規検出法の確立
		岡田朝美, 山田美鈴, 森博康, 明比祐子, 倉橋清衛, 吉田守美子, 遠藤逸朗, 粟飯原賢一, 松久宗英, 黒田暁生. 四国医学雑誌, Vol.77, No.5,6, 249-245, 2021年.
		症例報告　診断に時間を要した高齢者の甲状腺クリーゼの1例
		桝田志保, 吉田守美子, 工藤千晶, 辻本賀美, 安井沙耶, 遠藤ふうり, 三井由加里, 倉橋清衛, 遠藤逸朗, 轟貴史, 安倍正博日本老年医学会雑誌　2021 年 58 巻 1 号 p. 158-163
		歩行不能だったが，多職種の高度な連携と患者特性に配慮したケアにより自宅生活可能となった高度肥満症の一例
		川原綾香, 倉橋清衛, 工藤千晶, 鎌田基夢, 加藤真介, 富岡有紀子, 辻本賀美, 安井沙耶, 遠藤ふうり, 桝田志保, 三井由加里, 吉田守美子, 粟飯原賢一, 遠藤逸朗, 福本誠二, 松久宗英, 安倍正博四国医学雑誌. (2021). 76, 317-322
		術前スクリーニングで偶然発見された先天性プレカリクレイン欠乏症の1症例
		菅﨑幹樹, 徳永尚樹, 池亀彰茂, 中尾隆之, 大浦雅博, 三木浩和, 長井幸二郎, 高山哲治医学検査 Vol.70 No.1 (2021) pp. 132–137


		【総説】
2025		MGUSとくすぶり型骨髄腫の診療での現状と将来展望
		原田武志. 血液内科, 90巻4号, Page 375-382.
		多発性骨髄腫におけるCD38の役割と1q増幅との関連
		井上雄介, 原田武志, 大原菜摘, 中川裕美, 漆原南実, 中尾隆之. サイトメトリーリサーチ, 35巻1号, Page1-7.
		骨粗鬆症治療薬による高カルシウム血症、低カルシウム血症、静脈血栓塞栓症
		遠藤逸朗. 月刊薬事　骨粗鬆症治療のEvidence Update, 67巻15号 P.86-92
2024		内分泌疾患. メディカルスタッフのための内科学　第5版
		遠藤逸朗. 医学出版社 P.165-185
		【著書】
2025		テスト
		テスト

Awards, etc.

受賞など

Year

Month

2025

前田悠作：日本血液学会中国・四国地方会若手奨励賞（品川賞）

学会名

第64回日本血液学会中国四国地方会

会期

2025年3月8日（日）

会場

高知県立県民文化ホール

演題名

濾胞性リンパ腫の加療中に発症したCD4陽性のEBV陽性節性T/NK細胞リンパ腫

2025

学会名

会期

会場

演題名

Symposiums, etc.

シンポジウムなど

Year	Month
2024 2024	06	三木浩和：第44回日本骨形態計測学会　シンポジウム「がんと骨形態」学会名第44回日本骨形態計測学会会期 2024年6月21日（金）～6月23日（日）会場コラッセふくしま（福島県福島市）演題名多発性骨髄腫における骨病変の分子病態とそのマネージメント
2024	06	遠藤逸朗 : The 12th Seoul Symposium on Bone Health　& the 36th Spring Scientific Congress of the Korean Society for Bone and Mineral Research. シンポジウム学会名 The 12th Seoul Symposium on Bone Health & the 36th Spring Scientific Congress of the Korean Society for Bone and Mineral Research. 会期 2024年6月21日（金）～6月23日（日）会場コラッセふくしま（福島県福島市）演題名多発性骨髄腫における骨病変の分子病態とそのマネージメント
2024	05	原田武志：第49回日本骨髄腫学会学術集会シンポジウム「骨病変の治療・管理」学会名第49回日本骨髄腫学会学術集会会期 2024年5月31日（金）～6月2日（日）会場福岡国際会議場演題名骨髄腫-骨相互作用：病態から治療開発へ
2024	05	原田武志：第49回日本骨髄腫学会学術集会シンポジウム「免疫微小環境を標的とした治療法」学会名第49回日本骨髄腫学会学術集会会期 2024年5月31日（金）～6月2日（日）会場福岡国際会議場演題名破骨細胞によるBCMA標的治療効果の減弱機序
2023 2023	09	三木浩和：第10回日本アミロイドーシス学会学術集会 Featured research session 学会名第10回日本アミロイドーシス学会学術集会会期 2023年9月23日（土）会場高知市文化プラザかるぽーと演題名ラマン分光法を用いたアミロイドーシスに対する新規迅速診断法の開発
2023	05	原田武志：第48回日本骨髄腫学会学術集会　プレナリーセッション学会名第48回日本骨髄腫学会学術集会会期 2023年5月26日（金）～28日（金）会場浜松町コンベンションホール & Hybridスタジオ演題名プレナリーセッション「骨髄腫の進展における可溶性SLAMF7による炎症惹起の役割」
2023	05	井上雄介：第48回日本骨髄腫学会学術集会　プレナリーセッション学会名第48回日本骨髄腫学会学術集会会期 2023年5月26日（金）～28日（金）会場浜松町コンベンションホール & Hybridスタジオ演題名プレナリーセッション「骨髄腫細胞の内在的および外因子によるBCMA発現制御機構」
2022 2022	07	安倍正博：第40回日本骨代謝学会学術集会　シンポジウム学会名第40回日本骨代謝学会学術集会会期 2022年7月22日（金）～23日（土）会場長良川国際会議場演題名骨転移病態の基礎：オーバービュー
2022	05	安倍正博：第47回日本骨髄腫学会学術集会　特別シンポジウム学会名第47回日本骨髄腫学会学術集会会期 2022年5月20日（金）～22日（日）会場岐阜グランドホテル演題名 Perspective of international collaboration in the JSM
2022	05	三木浩和：第47回日本骨髄腫学会学術集会　シンポジウム学会名第47回日本骨髄腫学会学術集会会期 2022年5月20日（金）～22日（日）会場岐阜グランドホテル演題名 Diagnostic efficacy of non-invasive liver stiffness assessment using shear wave elastography for hepatic AL amyloidosis
2022	05	原田武志：第47回日本骨髄腫学会学術集会　シンポジウム学会名第47回日本骨髄腫学会学術集会会期 2022年5月20日（金）～22日（日）会場岐阜グランドホテル演題名 Therapeutic impact of targeting RNA editing enzyme ADAR1 on myeloma cells with 1q amplification.